Edesa Biotech, Inc. Net Income (Loss) Attributable to Parent in USD from 2012 to Q2 2025

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Edesa Biotech, Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from 2012 to Q2 2025.
  • Edesa Biotech, Inc. Net Income (Loss) Attributable to Parent for the quarter ending June 30, 2025 was -$1.75M, a 4.87% decline year-over-year.
  • Edesa Biotech, Inc. Net Income (Loss) Attributable to Parent for the twelve months ending June 30, 2025 was -$5.92M, a 14.6% increase year-over-year.
  • Edesa Biotech, Inc. annual Net Income (Loss) Attributable to Parent for 2024 was -$6.17M, a 26.3% increase from 2023.
  • Edesa Biotech, Inc. annual Net Income (Loss) Attributable to Parent for 2023 was -$8.37M, a 52.3% increase from 2022.
  • Edesa Biotech, Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$17.5M, a 31.5% decline from 2021.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)
Net Income (Loss) Attributable to Parent, Annual (USD)
Net Income (Loss) Attributable to Parent, YoY Annual Growth (%)

Edesa Biotech, Inc. Quarterly Net Income (Loss) Attributable to Parent (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2025 -$5.92M -$1.75M -$81.3K -4.87% Apr 1, 2025 Jun 30, 2025 10-Q 2025-08-08
Q1 2025 -$5.84M -$1.59M +$271K +14.6% Jan 1, 2025 Mar 31, 2025 10-Q 2025-05-14
Q4 2024 -$6.11M -$1.62M +$61.2K +3.65% Oct 1, 2024 Dec 31, 2024 10-Q 2025-02-14
Q3 2024 -$6.17M -$962K +$758K +44.1% Jul 1, 2024 Sep 30, 2024 10-K 2024-12-13
Q2 2024 -$6.93M -$1.67M +$317K +16% Apr 1, 2024 Jun 30, 2024 10-Q 2025-08-08
Q1 2024 -$7.25M -$1.86M +$473K +20.3% Jan 1, 2024 Mar 31, 2024 10-Q 2025-05-14
Q4 2023 -$7.72M -$1.68M +$656K +28.1% Oct 1, 2023 Dec 31, 2023 10-Q 2025-02-14
Q3 2023 -$8.37M -$1.72M +$1.09M +38.9% Jul 1, 2023 Sep 30, 2023 10-K 2024-12-13
Q2 2023 -$9.47M -$1.98M +$3.8M +65.7% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-09
Q1 2023 -$13.3M -$2.33M +$2.23M +48.9% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-10
Q4 2022 -$15.5M -$2.33M +$2.04M +46.7% Oct 1, 2022 Dec 31, 2022 10-Q 2024-02-09
Q3 2022 -$17.5M -$2.81M +$872K +23.7% Jul 1, 2022 Sep 30, 2022 10-K 2023-12-15
Q2 2022 -$18.4M -$5.79M -$1.03M -21.6% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-09
Q1 2022 -$17.4M -$4.57M -$2.31M -102% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-11
Q4 2021 -$15.1M -$4.38M -$1.74M -66% Oct 1, 2021 Dec 31, 2021 10-Q 2023-02-10
Q3 2021 -$13.3M -$3.69M -$1.67M -83% Jul 1, 2021 Sep 30, 2021 10-K 2022-12-16
Q2 2021 -$11.7M -$4.76M -$2.99M -170% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-12
Q1 2021 -$8.68M -$2.26M -$770K -51.7% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-13
Q4 2020 -$7.91M -$2.64M -$1.54M -141% Oct 1, 2020 Dec 31, 2020 10-Q 2022-02-14
Q3 2020 -$6.36M -$2.01M Jul 1, 2020 Sep 30, 2020 10-K 2021-12-28
Q2 2020 -$1.77M -$472K -36.5% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-13
Q1 2020 -$1.49M -$961K -182% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-14
Q4 2019 -$1.09M -$729K -200% Oct 1, 2019 Dec 31, 2019 10-Q 2021-02-16
Q2 2019 -$1.29M -$882K -214% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-12
Q1 2019 -$529K +$824K +60.9% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-15
Q4 2018 -$365K +$1.04M +74% Oct 1, 2018 Dec 31, 2018 10-Q 2020-02-13
Q2 2018 -$4.39M -$412K +$809K +66.3% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-14
Q1 2018 -$5.19M -$1.35M -$249K -22.5% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-08
Q4 2017 -$4.95M -$1.4M +$84.9K +5.72% Oct 1, 2017 Dec 31, 2017 10-Q 2019-02-05
Q3 2017 -$5.03M -$1.22M +$120K +8.97% Jul 1, 2017 Sep 30, 2017 10-K 2018-11-30
Q2 2017 -$5.15M -$1.22M -$26.3K -2.2% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-08
Q1 2017 -$5.12M -$1.1M -$243K -28.2% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-07
Q4 2016 -$4.88M -$1.49M +$144K +8.84% Oct 1, 2016 Dec 31, 2016 10-Q 2018-02-07
Q3 2016 -$5.03M -$1.34M +$196K +12.8% Jul 1, 2016 Sep 30, 2016 10-K 2017-12-01
Q2 2016 -$5.22M -$1.19M -$1.66M -357% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-09
Q1 2016 -$3.56M -$861K -$435K -102% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-09
Q4 2015 -$3.13M -$1.63M -$286K -21.3% Oct 1, 2015 Dec 31, 2015 10-Q 2017-02-06
Q3 2015 -$2.84M -$1.54M -$2.67M -236% Jul 1, 2015 Sep 30, 2015 10-K 2017-12-01
Q2 2015 -$178K $464K -$2.94M -86.4% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-09
Q1 2015 $2.77M -$426K +$1.01M +70.3% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-09
Q4 2014 $1.76M -$1.34M +$4.23M +75.9% Oct 1, 2014 Dec 31, 2014 10-Q 2016-02-08
Q3 2014 $1.13M +$1.37M Sep 1, 2014 Sep 30, 2014 10-K 2016-12-14
Q2 2014 -$3.84M $3.41M Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-10
Q1 2014 -$1.43M Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-11
Q4 2013 -$5.58M Oct 1, 2013 Dec 31, 2013 10-Q 2015-02-09
Q3 2013 -$240K Sep 1, 2013 Sep 30, 2013 10-Q 2015-02-09

Edesa Biotech, Inc. Annual Net Income (Loss) Attributable to Parent (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 -$6.17M +$2.2M +26.3% Oct 1, 2023 Sep 30, 2024 10-K 2024-12-13
2023 -$8.37M +$9.17M +52.3% Oct 1, 2022 Sep 30, 2023 10-K 2024-12-13
2022 -$17.5M -$4.21M -31.5% Oct 1, 2021 Sep 30, 2022 10-K 2023-12-15
2021 -$13.3M -$6.98M -110% Oct 1, 2020 Sep 30, 2021 10-K 2022-12-16
2020 -$6.36M Oct 1, 2019 Sep 30, 2020 10-K 2021-12-28
2018 -$1.54M +$3.49M +69.5% Jan 1, 2018 Dec 31, 2018 10-KT 2019-12-12
2017 -$5.03M -$4.57K -0.09% Oct 1, 2016 Sep 30, 2017 10-K 2018-11-30
2016 -$5.03M -$2.18M -76.8% Oct 1, 2015 Sep 30, 2016 10-K 2017-12-01
2015 -$2.84M +$5.6M +66.3% Oct 1, 2014 Sep 30, 2015 10-K 2017-12-01
2014 -$8.44M +$6.06M +41.8% Sep 1, 2013 Aug 31, 2014 10-K 2016-12-14
2013 -$14.5M -$8.97M -162% Sep 1, 2012 Aug 31, 2013 10-K 2015-12-14
2012 -$5.53M Sep 1, 2011 Aug 31, 2012 10-K 2014-11-21
* An asterisk sign (*) next to the value indicates that the value is likely invalid.